About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Evaluation of MyoStrain™ in Clinical Practice | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT03825224

Evaluation of MyoStrain™ in Clinical Practice

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Lead sponsor: University of Kansas Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Kansas Medical Center

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI)
•The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies
•Provided written informed consent

Exclusion Criteria

•Contraindication to Magnetic Resonance Imaging

Related studies

Comparing Menghini-type Needle and Franseen-type Needle in EBUS-TBNA for Sarcoidosis

NCT06220526 · Suspected Sarcoidosis

Virtual Patient Groups for Sarcoidosis Associated Fatigue

NCT07073963 · Sarcoidosis, Fatigue, and more

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

Artificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)

NCT07329699 · Coronary Artery Disease, Chronic Coronary Syndrome, and more

Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

NCT06863155 · Coronary Artery Disease, Ischemic Heart Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 19, 2019Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment19

Start dateApr 2019

Last updatedNov 19, 2019

Condition

Cardiac Failure Coronary Artery Disease Sarcoidosis Amyloidosis Lupus+2 more

Locations shown

The University of Kansas Medical Center

Kansas City, Kansas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions